» Articles » PMID: 19740122

Hyperinsulinaemia in Migraineurs is Associated with Nitric Oxide Stress

Overview
Journal Cephalalgia
Specialties Neurology
Psychiatry
Date 2009 Sep 11
PMID 19740122
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

There is growing evidence that alterations in the insulin and glucose metabolism may be involved in the pathogenesis of migraine. Nitric oxide (NO) stress has been associated with migraine. However, the role of NO on the insulin and glucose metabolism in migraineurs has remained elusive to date. The aim of the present study was to investigate the insulin and glucose metabolism in migraineurs and to determine possible interactions with the NO pathway. One hundred and twenty non-obese probands participated in this study, including 48 migraineurs and 72 healthy volunteers. Various parameters of the NO pathway, glucose metabolism as well as body measurement parameters were determined. We found a highly significantly increased insulin and Homeostasis Model Assessment (HOMA)-index in migraine patients, whereas fasting glucose was decreased. Logistic regression revealed an odds ratio of 5.67 for migraine, when comparing the lowest with the highest quartile of HOMA. Multivariate analysis showed that HOMA, waist-to-length ratio and nitrite as parameters of NO stress were highly significantly correlated. We show here that hyperinsulinaemia is associated with migraine and, furthermore, is correlated with increased NO stress. These findings represent a new pathophysiological mechanism that may be of clinical relevance.

Citing Articles

Oxidative Stress and Migraine.

Jimenez-Jimenez F, Alonso-Navarro H, Garcia-Martin E, Espada-Rubio S, Agundez J Mol Neurobiol. 2024; 61(10):8344-8360.

PMID: 38499906 DOI: 10.1007/s12035-024-04114-7.


Cross-trait analyses identify shared genetics between migraine, headache, and glycemic traits, and a causal relationship with fasting proinsulin.

Islam M, Nyholt D Hum Genet. 2023; 142(8):1149-1172.

PMID: 36808568 PMC: 10449981. DOI: 10.1007/s00439-023-02532-6.


A Digital Therapeutic Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Real World Data from Two Prospective Studies.

Lelleck V, Schulz F, Witt O, Kuhn G, Klein D, Gendolla A Nutrients. 2022; 14(14).

PMID: 35889884 PMC: 9315551. DOI: 10.3390/nu14142927.


Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration.

Islam M, Nyholt D Genes (Basel). 2022; 13(5).

PMID: 35627115 PMC: 9141901. DOI: 10.3390/genes13050730.


Pathophysiological Bases of Comorbidity in Migraine.

Altamura C, Corbelli I, de Tommaso M, Di Lorenzo C, Di Lorenzo G, Di Renzo A Front Hum Neurosci. 2021; 15:640574.

PMID: 33958992 PMC: 8093831. DOI: 10.3389/fnhum.2021.640574.